{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:14:23Z","timestamp":1778667263869,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.urology.2025.04.042","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T05:10:30Z","timestamp":1745557830000},"page":"275-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Exploring the Clinical Landscape of Priapism Related to Intracavernosal Injection Therapy: Patient Characteristics, Management Patterns, and Erectile Dysfunction Outcomes"],"prefix":"10.1016","volume":"204","author":[{"given":"Joseph A.","family":"Borrell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Bettencourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago P.","family":"Furtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anael","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan J.","family":"Andino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sriram V.","family":"Eleswarapu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse N.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2025.04.042_bib1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jsxmed\/qdae008","article-title":"Erectile dysfunction prevalence in the United States: report from the 2021 National Survey of Sexual Wellbeing","volume":"21","author":"Mark","year":"2024","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2025.04.042_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amjmed.2006.06.010","article-title":"Prevalence and risk factors for erectile dysfunction in the US","volume":"120","author":"Selvin","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.urology.2025.04.042_bib3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.aju.2013.07.009","article-title":"Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: current information and new horizons","volume":"11","author":"Ferguson","year":"2013","journal-title":"Arab J Urol"},{"key":"10.1016\/j.urology.2025.04.042_bib4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.juro.2018.05.004","article-title":"Erectile dysfunction: AUA guideline","volume":"200","author":"Burnett","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2025.04.042_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.eururo.2021.06.007","article-title":"European Association of urology guidelines on sexual and reproductive health-2021 update: male sexual dysfunction","volume":"80","author":"Salonia","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2025.04.042_bib6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.juro.2012.08.089","article-title":"Long-term satisfaction and predictors of use of intracorporeal injections for post-prostatectomy erectile dysfunction","volume":"189","author":"Prabhu","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2025.04.042_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41443-019-0186-z","article-title":"Long-term intracavernosal injection therapy: treatment efficacy and patient satisfaction","volume":"32","author":"Bearelly","year":"2020","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2025.04.042_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/JU.0000000000002767","article-title":"The diagnosis and management of recurrent ischemic priapism, priapism in sickle cell patients, and non-ischemic priapism: an AUA\/SMSNA Guideline","volume":"208","author":"Bivalacqua","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2025.04.042_bib9","article-title":"Evaluating the management trends for priapism and assessing the risk of priapism after in-office intracavernosal injections: a cross-sectional analysis","author":"Leong","year":"2024","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2025.04.042_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/0974-7796.176874","article-title":"Noninvasive treatments for iatrogenic priapism: Do they really work? A prospective multicenter study","volume":"8","author":"Habous","year":"2016","journal-title":"Urol Ann"},{"key":"10.1016\/j.urology.2025.04.042_bib11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.5152\/tud.2017.59852","article-title":"Is there a relation between priapism occurring after penile doppler ultrasonography and international erectile function index score and erection hardness score levels?","volume":"43","author":"Sonmez","year":"2017","journal-title":"Turk J Urol"},{"key":"10.1016\/j.urology.2025.04.042_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jsxmed\/qdae031","article-title":"Delineating patient errors in an intracavernosal injection program","volume":"21","author":"Furtado","year":"2024","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2025.04.042_bib13","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.jsxm.2019.07.024","article-title":"Priapism from recreational intracavernosal injections in a high-risk metropolitan community","volume":"16","author":"Zhao","year":"2019","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2025.04.042_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.urology.2021.06.036","article-title":"Characteristics and long term follow up of men who suffer Ischemic Priapism secondary to recreational use of intracavernosal injectable medications","volume":"156","author":"Masterson","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.urology.2025.04.042_bib15","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10508-010-9619-y","article-title":"Recreational use of erectile dysfunction medications in undergraduate men in the United States: characteristics and associated risk factors","volume":"40","author":"Harte","year":"2011","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.urology.2025.04.042_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/ua.ua_33_22","article-title":"Recreational use of oral erectile dysfunction medications among male physicians\u2014a cross-sectional study","volume":"15","author":"Almannie","year":"2023","journal-title":"Urol Ann"},{"key":"10.1016\/j.urology.2025.04.042_bib17","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1111\/j.1743-6109.2012.02755.x","article-title":"Recreational use of erectile dysfunction medications and its adverse effects on erectile function in young healthy men: the mediating role of confidence in erectile ability","volume":"9","author":"Harte","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2025.04.042_bib18","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0022-5347(05)68269-9","article-title":"The causes of patient dropout from penile self-injection therapy for impotence","volume":"162","author":"Mulhall","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2025.04.042_bib19","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/sj.ijir.3901025","article-title":"Long-term efficacy and compliance of intracorporeal (IC) injection for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis","volume":"15","author":"Raina","year":"2003","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2025.04.042_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.2047-2927.2013.00155.x","article-title":"The role of intracavernosal injection therapy and the reasons of withdrawal from therapy in patients with erectile dysfunction in the era of PDE5 inhibitors","volume":"2","author":"Sung","year":"2014","journal-title":"Andrology"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042952500398X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042952500398X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:32:27Z","timestamp":1778664747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042952500398X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":20,"alternative-id":["S009042952500398X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2025.04.042","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the Clinical Landscape of Priapism Related to Intracavernosal Injection Therapy: Patient Characteristics, Management Patterns, and Erectile Dysfunction Outcomes","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2025.04.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}